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Synaptic vesicular accumulation of glutamate is a vital initial step in glutamate transmission.
We have previously shown that Rose Bengal, a polyhalogenated fluorescein analog, is a potent
inhibitor of glutamate uptake into synaptic vesicles. Here, we report the structural features of
Rose Bengal required for this inhibition. Various Rose Bengal-related compounds, with
systematic structural variations, were tested. Results indicate that the four iodo groups and the
phenyl group attached to the xanthene moiety are critical for potent inhibitory activity.
Replacement of these groups with two iodo groups and an alkyl group, respectively, results in
substantial reduction in potency. Of further interest in creating high potency is the critical
nature of the oxygen atom which links the two benzene rings of xanthene. Thus, the phenyl
group and multiple iodo groups, as well as the bridging oxygen of xanthene, are crucial
elements of Rose Bengal required for its potent inhibitory action.
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INTRODUCTION
Glutamate (Glu) is widely accepted as the major
excitatory neurotransmitter in the vertebrate central
nervous system, and Glu-mediated neurotransmis-
sion plays a key role in learning and memory for-
mation, as well as basic neural communication.
Aberrant Glu transmission is known to lead to vari-
ous pathological conditions in the central nervous
system. In the presynaptic terminal of neurons Glu is
transported into synaptic vesicles prior to exocytotic
release. The energy-dependent vesicular Glu uptake
system plays a vital role in the initial step of Glu
transmission by directing Glu into the synaptic vesi-
cle (1–6). It is distinct from the sodium-dependent
Glu uptake system present in the plasma membrane
responsible for re-uptake of released Glu (7,8). The
ATP-dependent vesicular Glu uptake system consists
of at least two functional components, v-type proton-
pump ATPase and Glu-specific transporters (1,3,9–
11). There are three isoforms of vesicular Glu trans-
porters having differential distributions (for reviews
see ref. 12). ATP hydrolysis generates an electro-
chemical proton gradient that serves as the driving
force for translocation of Glu from the cytosol into
the lumen space of synaptic vesicles in the presence of
low concentrations of chloride (8–10,13–15). In view
of the vesicular Glu uptake systems pivotal role in
the first phase of Glu synaptic transmission, vesicular
Glu transport has been considered a potential target
for manipulating Glu transmission.
Vesicular Glu uptake has been shown to be
inhibited by the ergot bromocriptine (16,17), the Glu
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analog trans-1-aminocyclopentane-1,3-dicarboxylate
(18,19), the highly charged anionic dyes Trypan Blue
and Chicago Blue (20), as well as an endogenous
inhibitory protein factor (21). Carrigan et al. have
synthesized various derivatives of quinoline-2,4-
dicarboxylic acid and showed that they act as com-
petitive inhibitors of vesicular Glu uptake (22,23).
Most of these agents are, however, membrane-im-
permeant, except for bromocriptine. Recently, the
polyhalogenated fluorescein derivative Rose Bengal
has been found to be a potent inhibitor of Glu uptake
into isolated synaptic vesicles (24). The high potency
of Rose Bengal has raised the possibility that it might
serve as a prototype xenobiotic regulatory agent
which could alter vesicular Glu storage and Glu
synaptic transmission. In an effort to identify the
pharmacophore of Rose Bengal, we have here studied
the structure–activity relationship of certain fluores-
cein derivatives in inhibiting vesicular Glu uptake.
EXPERIMENTAL PROCEDURE
Fluorescein-related test compounds listed in Table I were
purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise
noted. Stock solutions of each compound were first prepared to a
concentration of 10 mM (DMSO) based on weight, and adjusted
by dilution to 5 mM, after concentration was determined by
spectrophotometry based upon the following molar extinction
coefficients: 96,100 M)1 cm)1 at 549 nm (Rose Bengal) in 1%
Na2CO3; 99,400 M
)1cm)1 at 558 nm (Rose Bengal lactone) in
methanol; 83,100 M)1 cm)1 at 526 nm (Erythrosin B) in 1%
Na2CO3; 108,000 M
)1 cm)1 at 530 nm (Erythrosin B lactone) in
methanol; 84,200 M)1 cm)1 at 538 nm (Erythrosin B isothiocya-
nate lactone) in methanol; 84,000 M)1 cm)1 at 517 nm (Eosin Y) in
1% Na2CO3; 107,000 M
)1 cm)1 at 523 nm (Eosin Y lactone) in
methanol; 52,900 M)1 cm)1 at 517 nm (Eosin B) in 1% Na2CO3;
89,609 M)1 cm)1 at 520 nm (methyl Eosin) in 1% Na2CO3;
270,600 M)1 cm)1 at 533 nm (ethyl Eosin) in 1% Na2CO3;
13,200 M)1 cm)1 at 518 nm (Eosin B lactone) in 0.1 M NaOH;
145,100 M)1 cm)1 at 512 nm (2¢,7¢-dichlorofluorescein lactone) in
ethanol plus 1 drop of 1 M NaOH; 57,300 M)1 cm)1 at 516 nm
(diiodofluorescein) in methanol plus 1 drop of 1 M NaOH;
104,983 M)1 cm)1 at 548 nm (Phloxine B) in 50% ethanol plus 1%
Na2CO3; 24,428 M
)1 cm)1 at 518 nm (tetrachlorofluorescein) in
methanol plus 1 drop of 1 M NaOH. Methyl Rose Bengal, benzyl
Rose Bengal, decarboxylated Rose Bengal, and 2,3,5,7-tetra-
iiodosuccinylfluorescein were the generous gift of Dr. F. Amat-
Guerri, Consejo Superior de Investigaciones Cientificas, Instituto
de Quimica Organica General, Madrid, Spain (25,26) and prepared
as 5 mM stocks; the concentration of these compounds was
determined based upon weight.
Preparation of Synaptic Vesicles from Rat Brain
Frozen brains from Sprague–Dawley rats (body weight
150 g) were purchased from Pel-Freez Biologicals (Rogers, AR)
and stored at )80C. Thirty-five frozen rat brains were thawed for
15 min on ice in 1.0 l of 0.32 M sucrose solution containing
4 mM Tris–HCl (pH 7.4), 0.1 mM DTT, and 6–7 brains
homogenized in 170 ml aliquots, using a 225-ml glass Dounce
homogenizer fitted with a Teflon pestle. The resulting homogenate
was centrifuged at 1000 · gmax (Sorvall GSA rotor, 2500 rpm) for
10 min, and the supernatant collected and centrifuged at
11,700 · gmax (Sorvall GSA rotor, 9000 rpm) for 20 min. The
resulting supernatant was discarded. The P2 synaptosomal pellets
were homogenized in an equal volume of ice-cold Krebs–Ringer
buffer (KRB) containing 150 mM NaCl, 2.4 mM KCl, 1.2 mM
Na2 HPO4, 1.2 mM CaCl2, 1.2 mM MgSO4, 0.1 mM DTT, and
5 mM HEPES buffered to pH 7.4 with Tris base. The KRB-
suspended P2 crude synaptosomes were pelleted by centrifugation
for 10 min at 6000 · gmax (Sorvall GSA rotor, 6,000 rpm). The
KRB-washed P2 synaptosomal pellets were then subjected to
hypotonic osmotic shock by homogenization in 360 ml of ice-cold
6 mM Tris, 0.1 mM DTT, buffered to pH 8.1 with malic acid,
and allowed to stand on ice for 45 min. After incubation at 0C,
the ruptured synaptosomal membrane and other cellular debris
were removed by centrifugation at 32,800 · gmax (Sorvall SS 34
rotor, 16,500 rpm) for 25 min. The supernatant was centrifuged at
150,000 · gmax (Beckman 45 Ti, 35,000 rpm) for 70 min. The
resulting pellets, which contain synaptic vesicles (crude synaptic
vesicle preparation), were resuspended in 0.32 M sucrose, 1 mM
DTT, 4 mM Tris–HCl (pH 7.4), at a protein concentration of
2 mg/ml, aliquoted into cryovials, and stored under liquid nitro-
gen. Typically 7–10 mg of crude synaptic vesicles (with respect to
protein) were obtained from 35 frozen rat brains. The vesicle
fraction had a specific uptake activity of 1.5–3.0 nmol Glu/mg
protein under our standard assay conditions described below. The
Table I. Effect of Halogenated Fluorescein Derivatives on ATP-
dependent Uptake of [3H]Glu into Synaptic Vesicles
Test compound IC50 (nM)
Rose Bengal lactone 18 ± 1.3
Rose Bengal 22 ± 0.7
Erythrosin B lactone 30 ± 3.0
Erythrosin B 35 ± 11.1
Methyl Rose Bengal 44 ± 2.6
Phloxine B 51 ± 0.8
Benzyl Rose Bengal 65 ± 6.8
Ethyl eosin 65 ± 5.2
Decarboxylated Rose Bengal 68 ± 3.5
Methyl eosin 117 ± 16.0
Eosin Y lactone 406 ± 40.0
Erythrosin B isothiocyanate lactone 689 ± 66.0
Eosin Y 743 ± 84.0
Diiodofluorescein 1,066 ± 77.0
2,4,5,7-Tetraiodosuccinylfluorescein 2,187 ± 24.0
Eosin B lactone 2,445 ± 481.0
3¢,3¢¢,5¢,5¢¢-Tetraiodophenolphthalein 3,850 ± 150.0
4,5,6,7-Tetrachlorofluorescein lactone 15,000 ± 984.0
Pyrogallol Red >32,000
2¢,7¢-Dichlorofluorescein lactone >64,000
Rat brain synaptic vesicles (10 lg) were pre-incubated in the ab-
sence or presence of different concentrations of each test compound
for 30 min at 0C, then assayed for ATP-dependent uptake for
10 min at 30C, as described in Experimental Procedure. An IC50
value was determined for each compound from sigmoidal dose–
response curves, an example of which is shown in Fig 2. Data
points represent the mean ± standard deviation (n = 3).
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ratio of ATP-dependent to ATP-independent uptake of Glu was
determined to be 83. The crude synaptic vesicles utilized in this
study were pooled from multiple preparations (140 rat brains). In
some experiments, these crude vesicles were suspended in 4 mM
HEPES–Tris (pH 7.4) containing 0.1 mM DTT, and further
purified by sucrose density gradient centrifugation (24,800 rpm
for 2 h in a Beckman 40.1 SW Ti rotor); the gradient consisted of
3.5 ml each of 0.2, 0.4, and 0.6 M sucrose in 4 mM HEPES–Tris
(pH 7.4) containing 0.1 mM DTT. The sample/0.2 M sucrose
layer including the interface between the 0.2 M sucrose layer and
the 0.4 M sucrose layer (fraction A), the 0.4 M sucrose layer
including the second interface (fraction B), and the 0.4 M sucrose
layer including the third interface (fraction C) were diluted 4- to
5-fold with 4 mM HEPES–Tris (pH 7.4) containing 1 mM DTT
and centrifuged at 150,000 · gmax (Beckman 70 Ti rotor) for
70 min. The pellets were suspended in 4 mM HEPES–Tris (pH
7.4) and analyzed for ATP-dependent Glu uptake. Fraction A
exhibited the highest specific activity of ATP-dependent Glu up-
take, and was used as the purified vesicle preparation.
L-Glu Uptake into Synaptic Vesicles
Vesicular Glu uptake was assayed by a modification of the
method of Naito and Ueda (7,8), as described previously by Kish
and Ueda (27). Aliquots (10 lg) of crude rat synaptic vesicles were
incubated for 10 min at 30C in a solution containing 20 mM
HEPES–KOH, pH 7.4, 0.25 mM sucrose, 4 mM MgSO4, 4 mM
KCl, 2 mM L-aspartic acid, 50 lM Glu, 2 mM ATP, and
3.7 · 104 Bq [G-3H]Glu (56 mmol/Ci) (Amersham) in a final vol-
ume of 0.1 ml. Test compounds were dissolved in DMSO and
added in 0.6 ll aliquots to give final concentrations between
0.14 nM and 25 lM. Synaptic vesicles were preincubated with test
compounds for 30 min at 0C. Uptake was initiated by addition of
a mixture of 2 mM ATP and 50 lM Glu (final concentration)
containing 1 lCi of [3H]Glu. After 10 min at 30C, 2.5 ml of ice-
cold 0.15 m KCl were added and the mixture immediately filtered
through Whatman GF/C glass–fiber filter paper (25 mm) using a
manifold under vacuum. The filters were washed 5 times with
2.5 ml of 0.15 M KCl and placed in scintillation vials with scin-
tillation cocktail (Cytoscint, ICN). The vials were shaken overnight
and radioactivity determined in a Beckman LS 6500 scintillation
spectrophotometer. Values obtained in the absence of ATP were
subtracted from those in the presence of ATP to calculate ATP-
dependent uptake activity. The amount of radioactive Glu trapped
on GF/C glass–fiber filter paper was indistinguishable from that
trapped on the Millipore HAWP filter (data not shown). Since the
rate of filtration with GF/C glass-fiber filter paper is greater, this
type of filter was used in all experiments described here.
Treatment of Data
IC50 values for test compounds were determined from sig-
moidal fit curves generated using the graphics software Origin
(Microcal Software, Inc.).
RESULTS AND DISCUSSION
Synaptic vesicles utilized in these studies were
prepared by a modification of a previously pub-
lished procedure (27); this method yields higher
specific activity with a higher degree of ATP-
dependency, yet requires no sucrose density gradient
ultracentrifugation. Frozen rat brains were thawed
in isotonic sucrose, homogenized, and a P2 fraction
prepared as previously described (27). The P2 syn-
aptosomal pellet was washed with Krebs–Ringer
buffer as opposed to isotonic sucrose prior to
hypotonic osmotic shock with 6 mM Tris–maleate,
pH 8.1. Typically 5–7 mg of crude synaptic vesicles
were obtainable from 35 rat brains, with ATP-
dependent Glu uptake of 1.5–3.0 nmol/mg protein
after a 10 min incubation at 30C. The ratio of
ATP-dependent to ATP independent Glu uptake is
on the order of 35 to 100. This modification results
in a 1.2- to 2.4-fold increase in specific activity when
compared to longer procedures utilizing bovine
brain and sucrose density gradient centrifugation
(27). The crude synaptic vesicles prepared in this
manner were compared with sucrose density gradi-
ent-purified synaptic vesicles with respect to re-
sponse to Rose Bengal lactone; preliminary
experiments had indicated that the lactone form of
Rose Bengal appeared slightly more potent than
Rose Bengal. As shown in Fig. 1, both crude and
purified vesicle preparations exhibited similar, if not
identical, sensitivities to RBL. Hence, the modified
crude vesicle preparation as described above was
used in the rest of the experiments presented here.
Structure–Activity Relationship
Uptake of [3H]Glu into synaptic vesicles (10 lg)
was measured in the presence of increasing concen-
trations of RBL during a 10-min incubation period at
30C. Vesicular uptake of [3H]Glu is plotted as a
function of inhibitor concentration. Figure 2 shows
an apparent sigmoidal dose–response curve for
inhibition of [3H]Glu uptake by RBL. The concen-
tration of RBL required to inhibit vesicular Glu up-
take by 50% (IC50) was 18 nM. For comparison, a
dose–response curve for tetraiodosuccinyl fluores-
cein, a less potent compound, was included.
Rose Bengal is a polyhalogenated derivative of
the fluorescent dye fluorescein. It consists of a poly-
iodinated xanthene moiety and a polychlorinated
benzoate moiety. Fluorescein by itself is ineffective in
inhibiting vesicular Glu uptake (24).
To determine the structural features of RBL that
account for potent inhibition of vesicular Glu uptake,
we determined the IC50 values for 18 other fluores-
cein-related dyes structurally similar to Rose Bengal.
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Sigmoidal dose–response curves were generated for
all compounds listed in Table I. The compounds are
listed in order of potency as judged by IC50 value for
inhibition of vesicular Glu uptake. The data in
Table I were obtained with vesicles pooled from
multiple preparations of 35 brains each.
Upon comparison of the IC50 values of various
fluorescein derivatives in Table I, structural features
responsible for inhibition of vesicular Glu uptake
have become apparent. Conversion of the carboxyl
group of Rose Bengal to the lactone form (RBL) does
not significantly alter potency. Rose Bengal was
found to have an IC50 of 22 nM and RBL an IC50 of
18 nM.
This minor difference in IC50 between Rose
Bengal and RBL indicates that the presence of an
acidic carboxyl group hardly affects potency. How-
ever, conversion of the carboxyl group of Rose
Bengal to either the methyl ester (IC50, 44 nM) or
benzyl ester (IC50, 65 nM) resulted in 2- and 3-fold
increases in IC50, respectively. Complete removal of
the carboxyl residue of Rose Bengal resulted in an
IC50 value of 68 nM.
Erythrosin B and Erythrosin B lactone have
similar structures to Rose Bengal and RBL, respec-
tively, but differ in that erythrosins lack the chloride
residues on the benzoate moiety. Erythrosin B and
Erythrosin B lactone were also found to be potent
inhibitors, with similar IC50 values of 35 and 30 nM,
respectively. Thus, the presence or absence of chlo-
ride and perhaps other halogens on the benzoate
moiety does not greatly affect potency. However, the
addition of a thiocyanate residue on the benzoate
moiety of Erythrosin B lactone does result in signif-
icant reduction of potency, increasing the IC50 to
690 nM. This 23-fold reduction in potency could be
due to the size of the thiocyanate group, which is
much larger than a single chloride residue. Removal
of the phenyl group from Erythrosin B markedly
reduces potency to micromolar concentrations, as
evident in tetraiodosuccinylfluorescein. Thus, the
phenyl group appears to substantially contribute to
potency.
Phloxine B differs from Rose Bengal in that it
contains bromine rather than iodine residues on the
xanthene moiety. Phloxine B was also found to be a
potent inhibitor of vesicular Glu uptake, with an IC50
value of 51 nM. However, removal of bromine resi-
dues from the xanthene moiety resulted in substantial
decrease in potency, as seen in tetrachlorofluorescein
(IC50, 15 lM). Thus, halogenation of the xanthene
moiety appears crucial for potent inhibition of ATP-
dependent Glu uptake.
For Phloxine B, in contrast to Rose Bengal, the
presence of chlorine residues on the benzoate moiety
appears to be required for high potency. Eosin Y
lacks halogens on the benzoate moiety and exhibited
a much lower potency (IC50, 740 nM) than Phloxine
B. However, if the benzoate is converted to either the
methyl or ethyl ester, the potency greatly increases;
their IC50 values are decreased to 120 and 65 nM,
respectively. Eosin Y lactone was twice as potent as
Eosin Y.
Fig. 1. Crude and sucrose density gradient-purified synaptic vesi-
cles have similar sensitivities to Rose Bengal lactone. Crude (top) or
purified (bottom) synaptic vesicle preparations (10 lg of protein
each) were subjected to ATP-dependent Glu uptake assay in the
presence of various concentrations of Rose Bengal lactone (RBL),
as described in Experimental Procedure. The control values (100%)
for vesicular Glu uptake were 1.53 nmol mg)1 10 min)1 with crude
synaptic vesicles and 1.90 nmol mg)1 10 min)1 with sucrose-gra-
dient purified synaptic vesicles.
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Erythrosin B lactone contains four iodine resi-
dues on the xanthene moiety and has an IC50 of
30 nM. Interestingly, tetrachlorofluorescein, which
lacks halogens on the xanthene moiety, was found to
be far less potent (IC50, 15 lM). Moreover, fluores-
cein derivatives bearing two halogen residues on the
xanthene moiety, such as diiodofluorescein lactone
(IC50, 1.1 lM) and 2¢,7¢-dichlorofluorescein lactone
(IC50 > 64 lM), showed substantially reduced
potency. Pyrogallol, which bears 4¢,5¢-dihydroxyl
groups instead of 4¢,5¢-diiodo groups, was also quite
ineffective (IC50 > 32 lM). These data demonstrate
the critical importance of having more than two
halogens, iodine in particular, on the xanthene
moiety.
Replacement of two bromine residues on Eosin
Y lactone with nitro groups results in higher IC50
values. Thus, Eosin B lactone was approximately 6-
fold less potent than Eosin Y lactone. The lactone
form of Eosin B was twice as potent as its non-lac-
tone form, similar to the case of Eosin Y lactone, as
mentioned above.
Finally, we have examined whether the oxygen
atom linking the two benzene rings of xanthene is
required for generating high potency. To this end, we
have tested 3¢,3¢¢,5¢,5¢¢-tetraiodophenolphthalein
(which differs from Erythrosin B only in lacking that
particular oxygen atom) for the ability to inhibit
vesicular Glu uptake. The IC50 value was determined
to be 3.9 lM, indicating a substantial reduction in
potency and hence a critical role of that oxygen atom
in creating a highly potent ligand.
We have shown that Rose Bengal, Erythrosin B,
and their lactone forms are the most potent inhibitors
of the vesicular Glu uptake system of all the fluo-
rescein derivatives tested here. Comparison of IC50
values for different halogenated derivatives of fluo-
rescein (Table I) has revealed that potency is depen-
dent on three key structural features. Polyhalogens
on the xanthene moiety seem to be most important.
Iodine residues on the xanthene moiety yield higher
potency than do bromine residues, as evident from
Erythrosin B (IC50, 35 nM) being a superior inhibitor
to Eosin Y (IC50, 740 nM). The phenyl group linked
to the xanthene moiety is also essential for high
potency. 2,4,5,7-tetraiodosuccinylfluorescein (IC50,
2.2 lM) devoid of the phenyl group is a far less
effective inhibitor than Erythrosin B lactone (IC50,
30 nM). On the other hand, the carboxyl group
attached to the phenyl group contributes little to the
potency. Of further interest is the observation indi-
cating that the oxygen atom linking the two benzene
rings of xanthene is crucial in conferring high inhi-
bition potency on Rose Bengal, Erythrosin B, and
their lactone forms. Without this oxygen atom, the
structural rigidity of these compounds would be lost.
Fig. 2. Effect of RBL and diiodofluorescein on ATP-dependent uptake of [3H]Glu into synaptic vesicles. Rat brain synaptic vesicles (10 lg)
were incubated in the absence or presence of various concentrations of test agents (final concentration) for 30 min at 0C, then assayed for
ATP-dependent uptake for 10 min at 30C, as described in Experimental Procedure. Uptake in the presence of carrier (0.6% DMSO) alone
was determined to be 2.90 nmol mg)1 10 min)1. Data points represent the mean ± standard deviation (n = 3).
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The two benzene rings would not be maintained on
the same plane, but would most likely be perpendic-
ular to each other. Thus, 2¢-,5¢-,6¢-, and 7¢-iodine
atoms would not be on the same plane. These
observations indicate that simply attaching bulky
groups such as iodine to the xanthene moiety is not
sufficient to create high potency; these groups would
have to assume a specific orientation toward each
other. This suggests that the potent inhibitory effect is
produced not through simple lipophilic interaction
with membrane lipids, but through a specific inter-
action with a protein or a common motif of certain
proteins. Thus, to convert fluorescein (an ineffective
agent) to a potent inhibitor would require attachment
of more than two bulkier halogen groups and a
hydrophobic group, such as the phenyl group, to the
xanthene moiety. The importance of the oxygen atom
connecting the two benzene rings is to be emphasized.
RBL, Rose Bengal, Erythrosin B, and Phloxine
B are likely to elicit the inhibitory effect on vesicular
Glu uptake via the same mechanism. The mechanism
of the inhibitory action is, however, not known. The
inhibitory effect of Rose Bengal is not due to any of
the following: (a) inhibition of ATP hydrolysis or
membrane potential formation, (b) blockade of Glu
binding to the transporter, (c) dissipation of mem-
brane potential, and (d) enhancing Glu efflux (24). It
has also been shown that Rose Bengal can inhibit
Na+-dependent Glu uptake into synaptosomes, but
only at substantially higher concentrations
(IC50 = 2 lM). Similar results were obtained with
RBL (IC50 = 0.7 lM for Glu uptake and
IC50 = 1.2 lM for GABA uptake). These observa-
tions are in accord with the studies by Logan and
Swanson (28) using brain homogenates, which have
shown that Erythrosin B inhibits neurotransmitter
accumulation with an IC50 of approximately 1 lM.
We have also observed that RBL inhibits other
electrochemical proton gradient-driven uptake sys-
tems, namely GABA and serotonin vesicular uptake
systems, with potencies (IC50 = 35 ± 5.8 nM for
GABA uptake and 38 ± 13 nM for serotonin up-
take) comparable to the potency for vesicular Glu
uptake. These observations indicate that electro-
chemical proton gradient-driven vesicular uptake
systems are far more sensitive to Rose Bengal,
Erythrosin B, and their lactone forms than are Na+-
gradient-driven plasma membrane uptake systems.
Although the inhibitory effect on Na+-dependent
plasma membrane uptake could be due to perturba-
tion of membranes through interaction with lipids, as
suggested by Logan and Swanson (28), the far more
potent inhibitory effects observed on electrochemical
proton gradient-dependent uptake systems, together
with the stringent requirement for a particular
3-dimensional structure of Rose Bengal, Erythrosin
B, and their lactone forms, may indicate that inhibi-
tion is occurring through interaction with a protein
component. Based upon the observations mentioned
above, we suggest that RBL, as well as related com-
pounds such as Rose Bengal, Erythrosin B, and
Phloxine B, may block, with high potency, the elec-
trochemical proton gradient-induced conformational
change of the vesicular transporter or proton efflux,
both necessary for transmitter transport to occur
(9,10,15,29,30).
In conclusion, multiple bulkier halogens and the
phenyl group (but not the alkyl group) attached to
the xanthene moiety, as well as the xanthenes oxygen
bridging, constitute the pharmacophore of Rose
Bengal and account for its potent inhibitory effect on
vesicular Glu uptake.
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